
Fully-developed technology for manufacture of recombinant human granulocyte colony stimulating factor (G-CSF). * High yielding process. * Quality matching branded product. * E. coli based expression. * Product registered in the Indian market. * Clinically well proven. * Unlimited supplies available for bulk and finished product in pre-filled syringes. * Complete product dossier available for registration.
Non-patented technology.
* Out-licensing of technology for recombinant G-CSF derived from E. coli * Registration of rHu G-CSF in non-regulated markets * Scouting for partners in Europe who will take full responsibility for registering one or more of the following products [Viz.: Recombinant human G-CSF, rIFN-alpha 2b, erythropoietin (EPO)] * Marketing tie-ups .